• PD-1 controls the immune system's cancer defence. • PD-L1 expression increases as oral precancerous lesions develop invasive OSCC. • PD-1 pathway identification in oral precancer may improve molecular aetiology and malignant transformation.
No takes yet. Share an insight, caveat, or question.
Muthupandian Saravanan (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: